Medicinal – Page 154

Research Topic: Medicinal

Editorial: Innovation in tackling the global challenge of eradicating antibiotic-resistant microorganisms

mycolabadmin

Antibiotic resistance is a serious global health problem causing millions of deaths annually. Scientists are developing new approaches to fight resistant bacteria, including using bacteriophages (viruses that attack bacteria), improving detection methods, and testing plant-based compounds. This editorial discusses 15 research papers showing various innovative strategies, emphasizing that we need multiple tools working together rather than relying on any single solution to solve this complex problem.

A cross-sectional study of the association between plant-based diet indices and kidney stones among Iranian adults

mycolabadmin

A study of nearly 10,000 Iranian adults found that people who followed a plant-based diet had a higher risk of developing kidney stones. However, the quality of plant-based eating did not matter—neither healthful nor unhealthful plant-based diets changed the risk significantly. This suggests that while plant-based diets are generally healthy, people at risk for kidney stones should ensure adequate calcium intake and proper hydration.

Spectrum of Fungal Infections in Continuous Ambulatory Peritoneal Dialysis: A 20-Year Retrospective Study From a Tertiary Care Center

mycolabadmin

This study examined fungal infections in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) over 20 years at an Indian medical center. Researchers found that yeast infections, particularly Candida tropicalis, were more common than mold infections, with Aspergillus flavus being the most frequent mold. The study identified several rare and emerging fungi causing these serious infections and tested their susceptibility to antifungal medications. Results show that removing the dialysis catheter combined with appropriate antifungal treatment is crucial for patient survival.

Invasive fungal infections caused by rare yeast-like fungi in adult patients: results of a prospective study

mycolabadmin

This study examined rare fungal infections in 30 critically ill adult patients over 18 years, finding that infections caused by uncommon yeasts like Trichosporon and Rhodotorula affected mainly long-term ICU patients with central lines. Despite treatment with antifungal medications, about 37% of patients died, highlighting the serious nature of these infections. The research emphasizes the importance of quickly identifying the specific fungus causing infection and using appropriate medications, along with removing infected catheters, to improve patient survival.

Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome

mycolabadmin

This research reveals that the types of fungi living in our gut are linked to fatty liver disease in ways we didn’t fully understand before. While researchers have long studied bacteria in our gut, they largely ignored fungi, which turns out to play an important role too. The study found that certain fungal species are more common in people with fatty liver disease, and these fungi influence the metabolites (chemical compounds) in the blood that affect liver health. By combining information about fungi, bacteria, and blood chemistry, scientists developed a test that could identify fatty liver disease with 77% accuracy, suggesting that looking at gut fungi could help doctors diagnose and treat this common liver condition.

Mushrooms Do Produce Flavonoids: Metabolite Profiling and Transcriptome Analysis of Flavonoid Synthesis in the Medicinal Mushroom Sanghuangporus baumii

mycolabadmin

Researchers discovered that the medicinal mushroom Sanghuangporus baumii produces 81 different flavonoids, compounds known for their health benefits including antioxidant and anti-cancer properties. Using advanced genetic and chemical analysis, they identified the genes and processes responsible for this flavonoid production in mushrooms, which differs from how plants make these compounds. By increasing the activity of a key gene called PAL, they were able to boost flavonoid production in the mushroom. This discovery opens new possibilities for using mushrooms as biological factories to produce flavonoids for medical and nutritional applications.

Mechanism Analysis of Amphotericin B Controlling Postharvest Gray Mold in Table Grapes

mycolabadmin

This research shows that amphotericin B, a natural compound produced by bacteria, can effectively prevent gray mold from spoiling table grapes after harvest. The compound works by damaging the mold’s cell membranes and also activates the grapes’ own defense systems. At a treatment level of 200 mg/L, it completely prevented mold growth on grapes over a three-day storage period, offering a safer, more environmentally friendly alternative to synthetic fungicides.

Caspofungin therapy in prosthetic valve endocarditis and candidemia due to itraconazole-resistant Candida glabrata (Nakaseomyces glabratus): A case report

mycolabadmin

A 13-year-old boy developed a serious fungal infection of his heart valve after receiving an artificial valve replacement. The initial antibiotic (itraconazole) did not work because the fungus became resistant, likely by forming a protective biofilm. After identifying the resistant fungus through specialized testing, doctors switched to a different medication called caspofungin. The patient fully recovered with this new treatment and remained healthy during follow-up, showing that combination of precise identification and targeted treatment can overcome antibiotic resistance.

COVID-19-associated Pulmonary Aspergillosis in Mechanically Ventilated Patients at 7 US Hospitals: Epidemiology and Estimated Likelihood of Invasive Pulmonary Aspergillosis—Results of the Prospective MSG-017 Study

mycolabadmin

A fungal infection caused by Aspergillus commonly occurs in COVID-19 patients on ventilators, affecting about 7% of cases. The study found that having this infection was linked to high death rates, but it was unclear whether the fungal infection itself or the severe COVID-19 caused the deaths. Single positive test results for the fungus are not reliable for diagnosis, and antifungal drugs did not improve survival rates.

Identification of potential neuroprotective compound from Ganoderma lucidum extract targeting microtubule affinity regulation kinase 4 involved in Alzheimer’s disease through molecular dynamics simulation and MMGBSA

mycolabadmin

Researchers used computer simulations to test five compounds from Reishi mushrooms against Alzheimer’s disease. They found that two compounds, ganoderic acid A and ganoderenic acid B, showed strong potential for blocking a harmful protein involved in the disease. These findings suggest Reishi mushrooms could be a source for new Alzheimer’s treatments, though further laboratory testing is needed.